Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Neuropharmacology

• Publication date

  2016-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.neuropharm.2016.08.032PMID 27590915
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structural basis for Smoothened regulation by its extracellular domains

  2016cited by this paper
• Allosteric coupling from G protein to the agonist binding pocket in GPCRs

  2016cited by this paper
• Allosteric Nanobodies Reveal the Dynamic Range and Diverse Mechanisms of GPCR Activation

  2016cited by this paper
• Structure-Based Statistical Mechanical Model Accounts for the Causality and Energetics of Allosteric Communication

  2016cited by this paper
• Molecular mechanism of positive allosteric modulation of the metabotropic glutamate receptor 2 by JNJ‐46281222

  2016cited by this paper
• High-Throughput Screening for Allosteric Modulators of GPCRs.

  2015cited by this paper
• Molecular Insights into Metabotropic Glutamate Receptor Allosteric Modulation

  2015cited by this paper
• Development of PET and SPECT Probes for Glutamate Receptors

  2015cited by this paper
• Molecular determinants of positive allosteric modulation of the human metabotropic glutamate receptor 2

  2015influential reference
• Major ligand-induced rearrangement of the heptahelical domain interface in a GPCR dimer.

  2015cited by this paper
• Positive allosteric modulators of metabotropic glutamate 2 receptors in schizophrenia treatment.

  2015cited by this paper
• Dynamics and modulation of metabotropic glutamate receptors.

  2015cited by this paper
• Co-operative binding assay for the characterization of mGlu4 allosteric modulators.

  2015cited by this paper
• Implications of metabotropic glutamate receptor structures for drug discovery in neurotherapeutics

  2015influential reference
• Why is dimerization essential for class-C GPCR function? New insights from mGluR1 crystal structure analysis

  2014cited by this paper
• Design and Synthesis of Systemically Active Metabotropic Glutamate Subtype-2 and -3 (mGlu2/3) Receptor Positive Allosteric Modulators (PAMs): Pharmacological Characterization and Assessment in a Rat Model of Cocaine Dependence

  2014cited by this paper
• Structure of a Class C GPCR Metabotropic Glutamate Receptor 1 Bound to an Allosteric Modulator

  2014cited by this paper
• Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain

  2014cited by this paper
• Identification of specific ligand-receptor interactions that govern binding and cooperativity of diverse modulators to a common metabotropic glutamate receptor 5 allosteric site.

  2014cited by this paper
• mGluR2 positive allosteric modulators: a patent review (2009 – present)

  2013cited by this paper
• Allosteric modulation of metabotropic glutamate receptors

  2013cited by this paper
• Positive allosteric modulators and silent allosteric modulators of opioid receptors

  2013cited by this paper
• Pharmacological Characterization of JNJ-40068782, a New Potent, Selective, and Systemically Active Positive Allosteric Modulator of the mGlu2 Receptor and Its Radioligand [3H]JNJ-40068782

  2013influential reference
• Metabotropic glutamate receptors as therapeutic targets for schizophrenia.

  2012cited by this paper
• G protein-coupled receptor transmembrane binding pockets and their applications in GPCR research and drug discovery: a survey.

  2011cited by this paper
• Allosteric modulation of metabotropic glutamate receptors.

  2011cited by this paper
• Metabotropic glutamate receptors: from the workbench to the bedside.

  2011cited by this paper
• Allosteric modulation of G protein-coupled receptors: a pharmacological perspective.

  2011cited by this paper
• Allosteric modulation of metabotropic glutamate receptors: structural insights and therapeutic potential.

  2011cited by this paper
• Structural determinants of allosteric antagonism at metabotropic glutamate receptor 2: mechanistic studies with new potent negative allosteric modulators

  2011cited by this paper
• Recent progress in the synthesis and characterization of group II metabotropic glutamate receptor allosteric modulators.

  2011cited by this paper
• Strategies for the identification of allosteric modulators of G-protein-coupled receptors.

  2011cited by this paper
• Dimers and beyond: The functional puzzles of class C GPCRs.

  2011cited by this paper
• Progress in Structure Based Drug Design for G Protein-Coupled Receptors

  2011influential reference
• Scaffold hopping from pyridones to imidazo[1,2-a]pyridines. New positive allosteric modulators of metabotropic glutamate 2 receptor.

  2010cited by this paper
• Chemical switch of a metabotropic glutamate receptor 2 silent allosteric modulator into dual metabotropic glutamate receptor 2/3 negative/positive allosteric modulators.

  2010cited by this paper
• Mutagenesis and Molecular Modeling of the Orthosteric Binding Site of the mGlu2 Receptor Determining Interactions of the Group II Receptor Antagonist 3H‐HYDIA

  2009cited by this paper
• 3-Benzyl-1,3-oxazolidin-2-ones as mGluR2 positive allosteric modulators: Hit-to lead and lead optimization.

  2009cited by this paper
• Positive allosteric modulators of the metabotropic glutamate receptor 2 for the treatment of schizophrenia

  2009cited by this paper
• Transposition of Three Amino Acids Transforms the Human Metabotropic Glutamate Receptor (mGluR)-3-Positive Allosteric Modulation Site to mGluR2, and Additional Characterization of the mGluR2-Positive Allosteric Modulation Site

  2008cited by this paper
• High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor.

  2007cited by this paper
• A Novel Family of Potent Negative Allosteric Modulators of Group II Metabotropic Glutamate Receptors

  2007cited by this paper
• High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor

  2007cited by this paper
• Determination of key amino acids implicated in the actions of allosteric modulation by 3,3'-difluorobenzaldazine on rat mGlu5 receptors.

  2006cited by this paper
• Comparison of the binding pockets of two chemically unrelated allosteric antagonists of the mGlu5 receptor and identification of crucial residues involved in the inverse agonism of MPEP

  2006cited by this paper
• Asymmetric Functioning of Dimeric Metabotropic Glutamate Receptors Disclosed by Positive Allosteric Modulators*

  2005cited by this paper
• An Automated System for the Analysis of G Protein-Coupled Receptor Transmembrane Binding Pockets: Alignment, Receptor-Based Pharmacophores, and Their Application

  2005influential reference
• SAR study of a subtype selective allosteric potentiator of metabotropic glutamate 2 receptor, N-(4-phenoxyphenyl)-N-(3-pyridinylmethyl)ethanesulfonamide.

  2004influential reference
• Mutational analysis and molecular modeling of the binding pocket of the metabotropic glutamate 5 receptor negative modulator 2-methyl-6-(phenylethynyl)-pyridine.

  2003cited by this paper
• Mutational Analysis and Molecular Modeling of the Allosteric Binding Site of a Novel, Selective, Noncompetitive Antagonist of the Metabotropic Glutamate 1 Receptor*

  2003cited by this paper
• Discovery of allosteric potentiators for the metabotropic glutamate 2 receptor: synthesis and subtype selectivity of N-(4-(2-methoxyphenoxy)phenyl)-N-(2,2,2- trifluoroethylsulfonyl)pyrid-3-ylmethylamine.

  2003cited by this paper
• Pharmacological characterization and identification of amino acids involved in the positive modulation of metabotropic glutamate receptor subtype 2.

  2003influential reference
• Positive allosteric modulators of metabotropic glutamate 1 receptor: Characterization, mechanism of action, and binding site

  2001cited by this paper
• Characterization of [(3)H]-LY354740 binding to rat mGlu2 and mGlu3 receptors expressed in CHO cells using semliki forest virus vectors.

  2000cited by this paper
• The Forgotten Serine

  2000influential reference
• Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor

  2000cited by this paper
• Synthesis of heterocyclic enol ethers and their use as group 2 metabotropic glutamate receptor antagonists.

  1999cited by this paper
• LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors.

  1998cited by this paper
• In vitro binding characteristics of a new selective group II metabotropic glutamate receptor radioligand, [3H]LY354740, in rat brain.

  1998cited by this paper
• LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors.

  1997influential reference
• Mutational analysis and molecular modeling of the nonapeptide hormone binding domains of the [Arg8]vasotocin receptor.

  1996cited by this paper

• Metabotropic glutamate receptor homo- and heterodimers exhibit distinct responses to orthosteric and allosteric ligands.

  2025cites this paper
• Synergistic Insights into Positive Allosteric Modulator and Agonist Using Gaussian Accelerated and Tau Random Acceleration Simulations in the Metabotropic Glutamate Receptor 2.

  2025cites this paper
• Effectiveness of positive allosteric modulators of metabotropic glutamate receptor 2/3 (mGluR2/3) in animal models of schizophrenia

  2025cites this paper
• Effects of the PAM of mGluR2, JNJ-46356479, on brain apoptotic protein levels in a mouse model of schizophrenia.

  2024cites this paper
• Distribution of [

  2023cites this paper
• Drugs Based on NMDAR Hypofunction Hypothesis in Schizophrenia

  2021cites this paper
• Structures of Gi-bound metabotropic glutamate receptors mGlu2 and mGlu4

  2021cites this paper
• Exploring the binding mechanism of positive allosteric modulators in human metabotropic glutamate receptor 2 using molecular dynamics simulations.

  2021cites this paper
• Modulation by chronic stress and ketamine of ionotropic AMPA/NMDA and metabotropic glutamate receptors in the rat hippocampus.

  2020cites this paper
• International Union of Basic and Clinical Pharmacology. CXI. Pharmacology, Signaling, and Physiology of Metabotropic Glutamate Receptors

  2020cites this paper
• A Combination of Flow and Batch Mode Processes for the Efficient Preparation of mGlu2/3 Receptor Negative Allosteric Modulators (NAMs).

  2018cites this paper
• Amelioration of PXR-mediated CYP3A4 induction by mGluR2 modulators.

  2018cites this paper
• Metabotropic glutamate receptors, 5 years on.

  2017cites this paper
• Molecular Switches of Allosteric Modulation of the Metabotropic Glutamate 2 Receptor.

  2017cites this paper
• The First Negative Allosteric Modulator for Dopamine D2 and D3 Receptors, SB269652 May Lead to a New Generation of Antipsychotic Drugs

  2017cites this paper